Valvular Disease in Marfan Syndrome: Surgical Considerations and Management
Purpose of Review
Detail the current strategies for the management of valve dysfunction in Marfan syndrome (MFS), understand the limitations of surgical interventions, and delineate the likely direction of future innovations.
Significant advances in both medical and surgical management of MFS have been made over the last 50 years. This has resulted in improved overall outcomes. As MFS patients age, new clinical challenges that were once rare have emerged and can require complex care strategies. Medical management has seen advances and focuses on anti-impulse and molecular-based pharmacotherapy, along with close monitoring with serial imaging to minimize acute aortic dissection risk by selecting appropriate timing of prophylactic surgical intervention with increasing aortic dimensions. Ongoing trials are evaluating other potential drug therapies with the ultimate goal of targeted treatment.
Over the last 50 years, significant advances have been made in the understanding and management of MFS. A move to prophylactic surgery for aortopathy and valve disease has progressed from a valve replacement to a valve-sparing strategy in many cases. However, the durability of these repairs is variable and the possibility of reintervention looms.
KeywordsMarfan syndrome Valvular disease Surgical management Connective tissue disorder
Compliance with Ethical Standards
Conflict of Interest
Ryan P. Plichta, Donald D. Glower, and G. Chad Hughes declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.Coselli JS, Volguina IV, LeMaire SA, Sundt TM, Connolly HM, Stephens EH, et al. Early and 1-year outcomes of aortic root surgery in patients with Marfan syndrome: a prospective, multicenter, comparative study. J Thorac Cardiovasc Surg. 2014;147(6):1758–66, 67 e1–4. https://doi.org/10.1016/j.jtcvs.2014.02.021.CrossRefPubMedGoogle Scholar
- 9.Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369. https://doi.org/10.1161/CIR.0b013e3181d4739e.CrossRefPubMedGoogle Scholar
- 25.•• David TE, David CM, Manlhiot C, Colman J, Crean AM, Bradley T. Outcomes of aortic valve-sparing operations in Marfan syndrome. J Am Coll Cardiol. 2015;66(13):1445–53. https://doi.org/10.1016/j.jacc.2015.07.041 This study examined the long-term outcomes of valve-sparing operations in patients with MFS. CrossRefPubMedGoogle Scholar
- 30.• Flynn CD, Tian DH, Wilson-Smith A, David T, Matalanis G, Misfeld M, et al. Systematic review and meta-analysis of surgical outcomes in Marfan patients undergoing aortic root surgery by composite-valve graft or valve sparing root replacement. Ann Cardiothorac Surg. 2017;6(6):570–81. https://doi.org/10.21037/acs.2017.11.06 This is a review and meta-analysis of MFS patients undergoing aortic root replacement surgery and compared valve-sparing and valve replacement strategies.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Boodhwani M, de Kerchove L, Glineur D, Poncelet A, Rubay J, Astarci P, et al. Repair-oriented classification of aortic insufficiency: impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg. 2009;137(2):286–94. https://doi.org/10.1016/j.jtcvs.2008.08.054.CrossRefPubMedGoogle Scholar
- 33.Price J, Magruder JT, Young A, Grimm JC, Patel ND, Alejo D, et al. Long-term outcomes of aortic root operations for Marfan syndrome: a comparison of Bentall versus aortic valve-sparing procedures. J Thorac Cardiovasc Surg. 2016;151(2):330–6. https://doi.org/10.1016/j.jtcvs.2015.10.068.CrossRefPubMedGoogle Scholar
- 34.Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, et al. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg. 2014;147(4):1202–10; discussion 10-1. https://doi.org/10.1016/j.jtcvs.2014.01.004.CrossRefPubMedGoogle Scholar
- 38.Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440–92. https://doi.org/10.1161/CIR.0000000000000029.CrossRefPubMedGoogle Scholar
- 43.Helder MR, Schaff HV, Dearani JA, Li Z, Stulak JM, Suri RM, et al. Management of mitral regurgitation in Marfan syndrome: outcomes of valve repair versus replacement and comparison with myxomatous mitral valve disease. J Thorac Cardiovasc Surg. 2014;148(3):1020–4; discussion 4. https://doi.org/10.1016/j.jtcvs.2014.06.046.CrossRefPubMedGoogle Scholar
- 45.• Javadikasgari H, Roselli EE, Aftab M, Suri RM, Desai MY, Khosravi M, et al. Combined aortic root replacement and mitral valve surgery: the quest to preserve both valves. J Thorac Cardiovasc Surg. 2017;153(5):1023–30 e1. https://doi.org/10.1016/j.jtcvs.2017.01.006 This study exmanines the pathology and surgical outcomes of patients with combined aortic root and mitral valve disease. CrossRefPubMedGoogle Scholar